Contact your healthcare provider immediately if you experience: Severe, persistent diarrhea preventing adequate hydration Clinical signs of dehydration (dizziness, dry mouth, dark urine, orthostatic symptoms) Blood in stool or severe abdominal pain Fever accompanying diarrhea Inability to maintain fluid intake due to concurrent vomiting Clinical reports have documented cases of acute kidney injury from severe volume depletion due to excessive diarrhea on GLP-1 therapy
Virus infection and replication cause delayed interferon response, severe inflammatory monocyte macrophage and neutrophil infiltration and uncontrolled flood of proinflammatory cytokines and chemokines [22]
This comprehensive approach acknowledges that muscle preservation and growth, especially with aging, requires more than just protein synthesis stimulation it demands optimization of the entire physiological environment for muscle adaptation
However, the SGLT2i treated cohort were less likely to develop heart failure (RR 0.44 [95% CI 0.23, 0.83] p =0.0092), CKD (RR 0.49 [95% CI 0.28, 0.86] p =0.0118) and be hospitalised for any cause (RR 0.59 [95% CI 0.46, 0.76] p 0.0001) when compared with the GLP-1 RA treated cohort